Health

Drugs may reduce the chances of premature menopause in breast cancer patients

Friday, May 30, 2014 (HealthDay News)-A drug called goserelin chemical treatment Reduce early risk menopause To breast cancer New studies seem to improve patients and survival.

early menopause Is one of the most upset side effects of chemical treatment Among young people breast cancer Patients and researchers pointed out.

Researchers have found that adding goserelin to chemotherapy significantly reduces early risk. menopause To breast cancer Increased the likelihood that patients and survivors will get Pregnant Later I will give birth to a healthy baby.

Goserelin (Zoladex) According to Dr. Kathy Alban, Principal Investigator at Loyola University Medical Center in Maywood, Illinois, the ovaries are temporarily “rested” during chemotherapy.

“In addition to mitigating early risk menopause, And all the associated symptoms menopause, Goserelin is very safe and may even improve survival, “she said in a Loyola news release.

The study included 257 premenopausal women under the age of 50 in the early stages. estrogen-Or Progesterone-Receptor negative breast cancer.. Patients were randomly assigned to receive either standard chemotherapy or chemotherapy and goserelin.

Two years later, 45% of women in the chemotherapy-only group showed early signs menopause, Compared to only 20 percent of them chemical treatment Plasgoserelin Group. In addition, the author states: pregnancy It was 11% in the chemotherapy-only group and 21% in the goserelin group.

Four years later, 89% of women chemical treatment Plasgoserelin group showed no signs or symptoms cancerCompared to 78% of the chemotherapy-only group. According to the report, 4-year survival was 92% in the goserelin group and 82% in the chemotherapy-only group.

“Premenopausal women starting early breast chemotherapy cancer You should consider this new option to prevent Primary ovarian insufficiencyThe authors of the study concluded.

The findings will be presented at the Annual Meeting of the American Clinical Society on Saturday. Oncology (ASCO) was held in Chicago. Studies presented at the conference are considered preliminary until published in a peer-reviewed medical journal.

Goserelin is an injectable drug that resembles the natural hormones that the body makes.It is approved by the U.S. Food and Drug Administration for the treatment of Prostate cancer, Certain benign gynecological disorders and certain breast cancers.

–Robert Plate

Medical news
Copyright © 2014 Health Day. all rights reserved.



Slide show

Breast Cancer Recognition: Symptomatology, Diagnosis, and Treatment
Watch slideshow

References

Source: Loyola University, News Release, May 30, 2014

Drugs may reduce the chances of premature menopause in breast cancer patients

Source link Drugs may reduce the chances of premature menopause in breast cancer patients

Back to top button